To highlight modifiable risk factors influencing the progression of chronic kidney disease (CKD), emphasizing its systemic nature and the importance of early identification and intervention.
Key Findings:
CKD is a major global health issue, with modifiable lifestyle and metabolic determinants, including inflammation, significantly influencing its progression.
Dietary factors, particularly sodium intake, and hypertension are critical in CKD development, especially in low socio-demographic regions.
Metabolic dysfunction, including insulin resistance, lipid abnormalities, and inflammation, is closely linked to CKD progression.
Emerging biomarkers like sUAR and Ins60/ApoA ratio show promise for early diagnosis and risk assessment in CKD, emphasizing the role of inflammation.
Interpretation:
The findings underscore the systemic nature of CKD, highlighting the need for integrated public health strategies and personalized interventions targeting modifiable risk factors, including metabolic and inflammatory pathways.
Limitations:
The studies may be limited by geographic and demographic variability in CKD risk factors, which can affect the generalizability of findings.
Further research is needed to validate emerging biomarkers and their clinical utility across diverse populations.
Conclusion:
Addressing modifiable risk factors through targeted interventions can significantly reduce the burden of CKD and improve patient outcomes, necessitating a combination of public health strategies and personalized care.
